To provide a preventive or a curative medicine for life-style related diseases such as diabetes and obesity.
A compound represented by formula (I) is provided [wherein, A1 is a halogenated lower alkyl or a halogenated lower alkoxy, or a group represented by formula (a) (wherein, X1 is O or SO2; R1 is a halogenated lower alkyl or a halogenated lower alkoxy); X2 is O or SO2; n is an integer of 2-6; Z is O or S; X3 is a single bond, a lower alkylene or a lower alkenylene; X4 is a single bond, NR2 (wherein, R2 is H, a lower alkyl or a lower alkoxy), CO, NHSO2, NHCO, NHCONH, or NHCSNH; B1 is an aryl which may have substituents, an aryl lower alkyl which may have substituents, an aryl lower alkenyl which may have substituents or a heteroaryl which may have substituents].
| JPS55118439 | RACEMIZATION OF OPTICALLY ACTIVE DERIVATIVE OF PHENYLACETIC ACID |
| WO/1999/011658 | META-BENZAMIDINE DERIVATIVES AS SERIN PROTEASE INHIBITORS |
| WO/1998/004247 | CELL ADHESION INHIBITORS |
AOYAMA YASUNORI
KOSHIDA SHUHEI
Next Patent: PRODUCTION METHOD OF PROPYLENE OXIDE